4.1 Article

COVID-19 and the Brain: Acute Encephalitis as a Clinical Manifestation

Journal

CUREUS JOURNAL OF MEDICAL SCIENCE
Volume 12, Issue 10, Pages -

Publisher

SPRINGERNATURE
DOI: 10.7759/cureus.10784

Keywords

rituximab; viral encephalitis; coronavirus disease 2019; acute encephalopathy

Ask authors/readers for more resources

Central nervous system (CNS) viral infections result in the clinical syndromes of aseptic meningitis or encephalitis. Although the primary target of coronavirus disease 2019 (COVID-19) is the respiratory system, it is increasingly being recognized as a neuropathogen. The hallmark clinical feature is altered mental status, ranging from mild confusion to deep coma. Most patients with encephalopathy or encephalitis are critically ill. We present a case of COVID- 19-related encephalitis who presented with acute delirium and new-onset seizures. The patient responded well to treatment with intravenous immunoglobulins and rituximab.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available